Plexiform Neurofibromas
📧 Sign up to get email alerts when something new happens for Plexiform Neurofibromas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas [Phase 2]
Phase 2 trial update for the MEK inhibitor selumetinib in adults with Neurofibromatosis Type 1 and inoperable plexiform neurofibromas; the s…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults [Phase 2]
Phase 2 trial evaluating cabozantinib for plexiform neurofibromas in NF1 patients (children and adults) has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain [Phase 3]
Phase 3 trial evaluating Acceptance and Commitment Training for adolescents and young adults with Neurofibromatosis Type 1 and plexiform neu…
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations [Phase 1, Phase 2]
Phase 1/2 study evaluating trametinib alone or with dabrafenib in cancers with V600 mutations or plexiform neurofibromas; completed with res…